venBio Partners as of Dec. 31, 2023
Portfolio Holdings for venBio Partners
venBio Partners holds 7 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rayzebio | 48.1 | $321M | 5.2M | 62.17 | |
| Alx Oncology Hldgs (ALXO) | 21.6 | $144M | 9.7M | 14.89 | |
| Pharvaris N V (PHVS) | 20.7 | $138M | 4.9M | 28.05 | |
| Harmony Biosciences Hldgs In (HRMY) | 5.0 | $33M | 1.0M | 32.30 | |
| Acelyrin (SLRN) | 4.3 | $29M | 3.9M | 7.46 | |
| Elevation Oncology (ELEV) | 0.2 | $1.6M | 2.9M | 0.54 | |
| Impel Neuropharma | 0.1 | $341k | 2.8M | 0.12 |
